Insider Transactions in Q1 2023 at Macrogenics Inc (MGNX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Jeffrey Stuart Peters Senior VP and General Counsel |
SELL
Open market or private sale
|
Direct |
5,372
-100.0%
|
$32,232
$6.03 P/Share
|
|
Feb 22
2023
|
Ezio Bonvini Sr VP, Research & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,619
-2.92%
|
$21,714
$6.55 P/Share
|
|
Feb 22
2023
|
Ezio Bonvini Sr VP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+7.04%
|
-
|
|
Feb 22
2023
|
Jeffrey Stuart Peters Senior VP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,378
-38.61%
|
$20,268
$6.55 P/Share
|
|
Feb 22
2023
|
Jeffrey Stuart Peters Senior VP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+50.0%
|
-
|
|
Feb 14
2023
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
500,000
+4.96%
|
$2,500,000
$5.07 P/Share
|
|
Jan 19
2023
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
150,000
+1.63%
|
$750,000
$5.3 P/Share
|